By Counterforce Health Team in Opdivo (nivolumab) —

Work With Your Doctor to Get Opdivo (Nivolumab) Approved by Aetna (CVS Health) in Michigan: Complete Guide

Quick Answer: Getting Opdivo (Nivolumab) Covered by Aetna (CVS Health) in Michigan

Aetna requires prior authorization for Opdivo across all oncology indications. Submit requests at least two weeks before treatment through the Availity provider portal with complete pathology, biomarker results, and treatment history. If denied, you have 60 days to file an internal appeal, then 127 days to request external review through Michigan DIFS. Start by gathering your insurance card, diagnosis details, and scheduling a focused visit with your oncologist to build your medical necessity case.

Table of Contents

Set Your Goal: Understanding Aetna's Requirements

Your primary objective is securing prior authorization for Opdivo through a collaborative effort with your oncologist. Aetna (CVS Health) requires comprehensive documentation that proves medical necessity and aligns with FDA-approved indications.

Coverage Requirements at a Glance:

Requirement What It Means Where to Find It
Prior Authorization Required for all oncology indications Aetna Precertification List
Submission Timeline At least 2 weeks before treatment Aetna PA Guidelines
Standard Review 30-45 days for decision Aetna policy documentation
Expedited Review 72 hours for urgent cases Michigan insurance regulations
Appeal Deadline 60 days for internal appeal Aetna member handbook

Partnership Strategy: Your role is to provide complete medical history and advocate for your care. Your doctor's role is to present clinical evidence and justify medical necessity using established guidelines. Together, you'll create a compelling case that addresses Aetna's specific criteria.

Tip: Aetna reports that 95% of complete requests are approved within 24 hours, emphasizing the importance of submitting thorough documentation upfront.

Prepare for Your Visit

Before meeting with your oncologist, compile a detailed timeline that will strengthen your prior authorization request.

Essential Information to Gather:

  1. Symptom Timeline
    • When symptoms first appeared
    • How they've progressed or changed
    • Impact on daily activities and quality of life
  2. Previous Treatments
    • All cancer treatments tried (chemotherapy, radiation, surgery)
    • Dates of treatment and duration
    • Specific reasons for discontinuation (progression, intolerance, contraindications)
    • Side effects experienced
  3. Current Status
    • Recent imaging results showing disease progression
    • Performance status changes
    • Laboratory values (if available)
  4. Insurance Information
    • Member ID and group number
    • Copy of insurance card
    • Any previous authorization attempts or denials

Questions to Ask Your Doctor:

  • "How does my case align with FDA-approved indications for Opdivo?"
  • "What biomarker testing do we need to support the request?"
  • "Are there specific NCCN guidelines that support Opdivo for my situation?"
  • "What documentation will make the strongest case to Aetna?"

Build Your Evidence Kit

Work with your healthcare team to assemble comprehensive supporting documentation.

Required Clinical Documentation:

  • Pathology Reports: Complete biopsy and surgical pathology confirming diagnosis with specific cancer type and staging
  • Biomarker Testing: PD-L1 expression, MSI-H/dMMR status, or other relevant molecular markers based on your cancer type
  • Imaging Studies: Recent CT, MRI, or PET scans showing disease extent and progression
  • Laboratory Results: Current blood work, liver function, kidney function as relevant to treatment eligibility
  • Treatment History: Detailed records of all prior therapies with dates, doses, and outcomes

Guideline Support: Your oncologist should reference current NCCN Guidelines and FDA labeling that support Opdivo use for your specific diagnosis and clinical scenario. For off-label uses, peer-reviewed literature from major oncology journals provides additional support.

Note: Counterforce Health specializes in helping patients and clinicians navigate complex prior authorization requirements by identifying the specific evidence needed for each payer's criteria.

Medical Necessity Letter Structure

Your oncologist will need to craft a detailed letter of medical necessity. Here's what should be included:

Essential Components:

  1. Patient Demographics & Diagnosis
    • Full name, date of birth, insurance ID
    • Specific cancer diagnosis with ICD-10 code
    • Date of diagnosis and current stage
  2. Clinical Rationale
    • Why Opdivo is the appropriate treatment choice
    • How it aligns with FDA indications and clinical guidelines
    • Patient-specific factors that make Opdivo optimal
  3. Treatment History
    • Previous therapies attempted with specific dates
    • Reasons for treatment changes (progression, toxicity, contraindications)
    • Documentation of treatment failures or intolerances
  4. Supporting Evidence
    • Biomarker results supporting Opdivo use
    • Current disease status and staging information
    • References to NCCN guidelines or peer-reviewed literature
  5. Urgency Statement
    • Risks associated with treatment delay
    • Expected benefits of timely Opdivo initiation
    • Alternative treatment options and why they're less suitable

Sample Opening: "I am writing to request prior authorization for Opdivo (nivolumab) for [Patient Name], a [age]-year-old patient with [specific cancer diagnosis] (ICD-10: [code]). Based on current NCCN guidelines and FDA-approved indications, Opdivo represents the most appropriate treatment option given this patient's clinical history and current disease status."

Support Your Doctor's Peer-to-Peer Review

If your initial request is denied, Aetna offers peer-to-peer reviews where your oncologist can speak directly with their medical director.

How to Help Your Doctor Prepare:

  1. Provide Availability Windows
    • Give your oncologist several time slots when you're available for urgent decisions
    • Ensure they have your current contact information
  2. Create a Case Summary
    • One-page summary of your diagnosis, treatments tried, and current status
    • List of specific questions or concerns about the denial
  3. Key Talking Points
    • Why Opdivo is medically necessary for your specific situation
    • How delay could impact your prognosis
    • Patient-specific factors that make alternatives inappropriate

Peer-to-Peer Request Timeline:

  • Must be requested within 14 days of denial
  • Aetna typically schedules within 3-5 business days
  • Decision usually provided within 24-48 hours after the call

After Your Visit: Documentation

Maintain organized records of all communications and submissions.

What to Save:

  • Copy of the prior authorization request
  • All supporting documentation submitted
  • Confirmation numbers or submission receipts
  • Timeline of when decisions are expected
  • Contact information for your case

Portal Communication: Use your patient portal to:

  • Message your care team with questions
  • Request copies of test results or clinical notes
  • Get updates on authorization status
  • Schedule follow-up appointments

Follow-Up Schedule:

  • Week 1: Confirm submission received
  • Week 3: Check on review status
  • Week 4: Request expedited review if urgent
  • Week 6: Prepare appeal documentation if needed

Respectful Persistence and Follow-Up

Effective advocacy requires consistent but respectful follow-up.

Communication Cadence:

  • Weekly check-ins during the initial review period
  • Bi-weekly updates if the case is under appeal
  • Immediate contact if your condition changes or urgent needs arise

How to Escalate Politely:

  1. Start with your oncologist's nurse or case manager
  2. Request to speak with the practice's prior authorization specialist
  3. Ask for a supervisor if standard timelines aren't being met
  4. Document all interactions with dates, names, and outcomes

When to Involve Administration:

  • If standard review timelines are exceeded without explanation
  • If you're not receiving responses to reasonable requests for updates
  • If there are discrepancies in information between different representatives

Appeals Process in Michigan

Michigan provides robust appeal rights through the Department of Insurance and Financial Services (DIFS).

Step-by-Step Appeals Timeline:

  1. Internal Appeal (Aetna)
    • Deadline: 60 days from denial letter
    • Decision Timeline: 30 days standard, 72 hours expedited
    • How to Submit: Online portal, mail, or fax
    • Required: Denial letter, updated medical evidence, physician letter
  2. External Review (Michigan DIFS)
    • Deadline: 127 days from final internal denial
    • Decision Timeline: 60 days standard, 72 hours expedited
    • How to Submit: DIFS Online Form or mail
    • Cost: Free to patients
    • Decision: Binding on Aetna

Required Documentation for DIFS Review:

  • Copy of all denial letters
  • Completed FIS 0018 form
  • Physician certification of urgency (for expedited requests)
  • Clinical evidence supporting medical necessity
  • Timeline of disease progression
Important: Michigan's 127-day deadline for external review is longer than the federal standard, giving you extra time to prepare a thorough appeal.

Contact Information:

Common Denial Reasons & Solutions

Understanding typical denial reasons helps you prepare stronger initial requests and appeals.

Denial Reason How to Address Required Documentation
Missing biomarker testing Provide all required test results PD-L1, MSI-H/dMMR, EGFR/ALK as applicable
Incomplete staging information Submit updated pathology and imaging Recent scans, pathology reports, clinical notes
Step therapy not completed Document prior treatment failures Treatment timeline, reasons for discontinuation
Not medically necessary Cite FDA/NCCN guidelines Medical necessity letter, literature support
Off-label use without support Provide clinical evidence Peer-reviewed studies, guideline references
Coding errors Correct and resubmit Accurate ICD-10 and prescription codes

Appeal Success Strategies:

  • Address each denial reason specifically in your appeal letter
  • Provide point-by-point rebuttals using medical evidence
  • Include updated clinical information if your condition has changed
  • Reference Aetna's own coverage policies when applicable

Systems like Counterforce Health can help identify exactly which evidence points will be most compelling for your specific denial reasons and payer requirements.

FAQ

How long does Aetna prior authorization take in Michigan? Standard review takes 30-45 days, but Aetna reports 95% of complete requests are decided within 24 hours. Expedited reviews for urgent cases are completed within 72 hours.

What if Opdivo is not on my formulary? You can request a formulary exception by providing documentation that formulary alternatives are inappropriate for your specific case, including prior treatment failures or contraindications.

Can I request an expedited appeal in Michigan? Yes. For expedited external review through DIFS, you need a physician letter stating that delay would seriously jeopardize your health. Decisions are made within 72 hours.

Does step therapy apply if I failed treatments outside Michigan? Yes, treatment history from any location counts toward step therapy requirements. Ensure your out-of-state records are included in your authorization request.

What happens if DIFS overturns Aetna's denial? The decision is binding. Aetna must provide coverage as directed by the independent review organization. DIFS will send written notice to both you and Aetna.

How much does Opdivo cost if I have to pay out-of-pocket? List price is approximately $7,943 per 240-mg vial, but actual regimen costs vary by cancer type and patient weight. Bristol Myers Squibb offers patient assistance programs for eligible patients.

Can someone else file appeals for me? Yes, in Michigan, your physician or another authorized representative can file appeals with your written consent. This is often helpful for complex cases.

What if I need Opdivo urgently while appeals are pending? Ask your oncologist about compassionate use programs or temporary bridge therapy. Some patients qualify for manufacturer-sponsored access while appeals are processed.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual policy terms and clinical circumstances. Always consult with your healthcare provider and insurance company for guidance specific to your situation. For official Michigan insurance regulations and appeal procedures, contact the Michigan Department of Insurance and Financial Services at 877-999-6442.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.